These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19133994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats.
    Wheal AJ, Bennett T, Randall MD, Gardiner SM.
    Br J Pharmacol; 2007 Nov; 152(5):717-24. PubMed ID: 17700721
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.
    Wheal AJ, Bennett T, Randall MD, Gardiner SM.
    Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361
    [Abstract] [Full Text] [Related]

  • 4. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
    Moezi L, Gaskari SA, Liu H, Baik SK, Dehpour AR, Lee SS.
    Br J Pharmacol; 2006 Dec; 149(7):898-908. PubMed ID: 17043671
    [Abstract] [Full Text] [Related]

  • 5. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L, Howlett AC, Mukhopadhyay S.
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696
    [Abstract] [Full Text] [Related]

  • 7. Complex regional haemodynamic effects of anandamide in conscious rats.
    Gardiner SM, March JE, Kemp PA, Bennett T.
    Br J Pharmacol; 2002 Apr 01; 135(8):1889-96. PubMed ID: 11959791
    [Abstract] [Full Text] [Related]

  • 8. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
    Bátkai S, Pacher P, Osei-Hyiaman D, Radaeva S, Liu J, Harvey-White J, Offertáler L, Mackie K, Rudd MA, Bukoski RD, Kunos G.
    Circulation; 2004 Oct 05; 110(14):1996-2002. PubMed ID: 15451779
    [Abstract] [Full Text] [Related]

  • 9. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
    Gomes FV, Casarotto PC, Resstel LB, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):434-8. PubMed ID: 21111767
    [Abstract] [Full Text] [Related]

  • 10. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.
    Eur J Neurosci; 2007 Dec 30; 26(12):3458-64. PubMed ID: 18052990
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP, Michaud JC, Le Fur G, Soubrié P.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov 30; 352(5):576-9. PubMed ID: 8751088
    [Abstract] [Full Text] [Related]

  • 12. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
    Silva GB, Atchison DK, Juncos LI, García NH.
    Am J Physiol Renal Physiol; 2013 Feb 15; 304(4):F376-81. PubMed ID: 23220721
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors.
    Wagner JA, Járai Z, Bátkai S, Kunos G.
    Eur J Pharmacol; 2001 Jul 06; 423(2-3):203-10. PubMed ID: 11448486
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed.
    Pakdeechote P, Dunn WR, Ralevic V.
    Br J Pharmacol; 2007 Nov 06; 152(5):725-33. PubMed ID: 17641668
    [Abstract] [Full Text] [Related]

  • 15. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B.
    Life Sci; 2016 Apr 15; 151():288-299. PubMed ID: 26969765
    [Abstract] [Full Text] [Related]

  • 16. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC.
    Biochem Pharmacol; 2007 Jun 15; 73(12):2004-11. PubMed ID: 17445778
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats.
    Gardiner SM, March JE, Kemp PA, Bennett T.
    Br J Pharmacol; 2009 Oct 15; 158(4):1143-52. PubMed ID: 19702785
    [Abstract] [Full Text] [Related]

  • 18. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR.
    Neuropharmacology; 2008 Jan 15; 54(1):129-40. PubMed ID: 17904589
    [Abstract] [Full Text] [Related]

  • 19. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.
    J Pharmacol Exp Ther; 2006 Mar 15; 316(3):969-82. PubMed ID: 16284279
    [Abstract] [Full Text] [Related]

  • 20. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
    Hartmann A, Fassini A, Scopinho A, Correa FM, Guimarães FS, Lisboa SF, Resstel LB.
    J Psychopharmacol; 2019 May 15; 33(5):606-614. PubMed ID: 30789299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.